Data on genetic alterations in seromucinous carcinoma are limited, although one international study showed mutations in ARID1A, KRAS, PIK3CA, and PTEN in 16%, 70%, 37%, and 19% of seromucinous carcinoma, respectively, based on analysis of 32 cases [21]. Here, PIK3CA is linked to carcinoma.